Sangamo Therapeutics
SGMO
#10559
Rank
NZ$51.83 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-85.81%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$34.55 Million. In 2025 the company made an earning of -NZ$0.19 Billion a decrease over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion3.65%
2025 -NZ$0.19 Billion9.71%
2024 -NZ$0.17 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.35 Billion9.79%
2021 -NZ$0.31 Billion41.52%
2020 -NZ$0.22 Billion23.17%
2019 -NZ$0.18 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$95.29 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$79.22 Million75.62%
2014 -NZ$45.11 Million0.13%
2013 -NZ$45.06 Million
2011 -NZ$60.57 Million43.66%
2010 -NZ$42.16 Million28.52%
2009 -NZ$32.81 Million-23.55%
2008 -NZ$42.91 Million2.45%
2007 -NZ$41.89 Million19.5%
2006 -NZ$35.05 Million50.78%
2005 -NZ$23.25 Million75%
2004 -NZ$13.29 Million-33.25%
2003 -NZ$19.9 Million-62.27%
2002 -NZ$52.74 Million102.82%
2001 -NZ$26.01 Million23.21%
2000 -NZ$21.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.92 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.36 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.74 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.28 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.13 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.23 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.47 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA